Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Podcasting since 2022 • 170 episodes
Beyond Biotech - the podcast from Labiotech
Latest Episodes
Play
Pichia pastoris: the microbial protein expression platform you’re probably underestimating
Today we’re diving into the world of expression systems with Iskander Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris, a methylotrophic yeast that’s revolutionizin...
•
36:02
Play
Biotech royalty deals on the rise and here to stay
In today's episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx. HCRx are pioneers in royalty-based financing, with a thirty year track record in biopharma investing. Clarke has led more than 60 royalty acq...
•
51:18
Play
Contraline's ADAM in the clinic: towards a new era of male contraception?
When it comes to contraception, most of the innovation in the last century has focused on providing contraceptive alternatives for women. The contraceptive pill was approved by the FDA in 1960, the first IUD approved in 1968, and the female con...
•
Episode 168
•
40:33
Play
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
Raising money in the gene therapy space can be tough right now but, for the right company and with the right team, there is still cash to be found. But how do you connect with investors, how do you get your science in front of the right people,...
•
Episode 167
•
44:49
Play
What’s next in immunology & inflammation R&D: The trends to watch
Immunology and inflammation are hot topics in biotech and biopharma, and innovations are emerging that can change the game for patients suffering from autoimmune, gastrointestinal, and metabolic disease. For top pharma companies, identifying th...
•
Episode 166
•
51:25